Gretel Dovale-Rosabal
Overview
Explore the profile of Gretel Dovale-Rosabal including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
26
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Reinoso F, Rodriguez A, Sanchez C, Claria B, Romero N, Espinosa A, et al.
Mar Drugs
. 2024 Dec;
22(12).
PMID: 39728122
A new antioxidant lipid (AL) was synthesized from rainbow trout () belly oil and cold-pressed maqui (CPM) ( (Mol.) Stuntz) seed oil via enzymatic interesterification using in supercritical CO medium....
2.
Claria B, Espinosa A, Rodriguez A, Dovale-Rosabal G, Bucarey J, Pando M, et al.
Antioxidants (Basel)
. 2024 Nov;
13(11).
PMID: 39594526
This study evaluated the effects of cold-pressed maqui ( (Mol.) Stuntz) seed oil (MO) on liver metabolism and biochemical markers in a high-fat diet (HFD) murine model. In it, the...
3.
Sanchez C, Rodriguez A, Reinoso F, Dovale-Rosabal G, Romero N, Espinosa A, et al.
Antioxidants (Basel)
. 2024 Jul;
13(7).
PMID: 39061913
This study focused on the oil extraction from freeze-dried maqui () by supercritical fluid extraction with carbon dioxide (SFE-CO). The basic objective was to optimize the oil yield and the...
4.
Dovale-Rosabal G, Espinosa A, Rodriguez A, Barriga A, Palomino-Calderon A, Romero N, et al.
Molecules
. 2022 Nov;
27(22).
PMID: 36431812
Obesity is the leading risk factor for developing metabolic (dysfunction)-associated fatty liver disease (MAFLD). The food industry has an essential role in searching for new strategies to improve primary food...
5.
Dovale-Rosabal G, Rodriguez A, Espinosa A, Barriga A, Aubourg S
Molecules
. 2021 Jun;
26(11).
PMID: 34067234
There is consistent evidence that long-chain polyunsaturated fatty acids (LCPUFA) belonging to the -3 series, i.e., eicosapentaenoic (20:5-3, EPA) and docosahexaenoic (22:6-3, DHA) acids, decrease the risk of heart, circulatory...
6.
Espinosa A, Ross A, Dovale-Rosabal G, La Fuente F, Uribe-Oporto E, Sacristan C, et al.
Molecules
. 2020 Jul;
25(14).
PMID: 32698439
Dietary intake of eicosapentaenoic/docosahexaenoic acid (EPA/DHA) reduces insulin resistance and hepatic manifestations through the regulation of metabolism in the liver. Obese mice present insulin resistance and lipid accumulation in intracellular...
7.
Dovale-Rosabal G, Rodriguez A, Contreras E, Ortiz-Viedma J, Munoz M, Trigo M, et al.
Molecules
. 2019 Apr;
24(9).
PMID: 31027319
This research focused on obtaining eicosapentaenoic acid (EPA, 20:5 -3) and docosahexaenoic acid (DHA, 22:6 -3) (EPA+DHA) concentrates from refined commercial salmon oil (RCSO). Independent variables of the complexation process...